| Wed, Nov 18, 2009 | | | LPATH, INC Financials EDGAR Online Financials (Wed, Nov 18)
| | Thu, Nov 12, 2009 | | | LPATH, INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 12)
| | Fri, Oct 23, 2009 | | | Lpath to Present at the 2009 BIOCOM Investor Conference Marketwire (Fri, Oct 23)
| | Tue, Oct 20, 2009 | | | Lpath Receives Grants From the National Institutes of Health and Publishes Key Paper in the Proceedings of the National Academy of Sciences Marketwire (Tue, Oct 20)
| | Thu, Oct 8, 2009 | | | Lpath's iSONEP Is Well Tolerated at All Dose Levels in a Phase 1 Trial in Wet-AMD Patients Marketwire (Thu, Oct 8)
| | Thu, Sep 24, 2009 | | | LPATH, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh EDGAR Online (Thu, Sep 24)
| | | Lpath and Merck Serono Extend ASONEP(TM) Collaboration Marketwire (Thu, Sep 24)
| | Mon, Aug 24, 2009 | | | LPATH, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Mon, Aug 24)
| | | Lpath Achieves Merck Serono Milestone Marketwire (Mon, Aug 24)
| | Tue, Aug 18, 2009 | | | Lpath Completes Enrollment of Patients in iSONEP(TM) Phase 1 Clinical Trial Marketwire (Tue, Aug 18)
| | Fri, Aug 14, 2009 | | | Lpath to Present at the Southern California Investor Conference Marketwire (Fri, Aug 14)
| | Wed, Aug 12, 2009 | | | LPATH, INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Aug 12)
| | Tue, Jul 7, 2009 | | | LPATH, INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits EDGAR Online (Tue, Jul 7)
| | Thu, Jul 2, 2009 | | | LPATH, INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant EDGAR Online (Thu, Jul 2)
| | Fri, Jun 5, 2009 | | | LPATH, INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online (Fri, Jun 5)
| | Thu, Jun 4, 2009 | | | Lpath Receives $3 Million Grant From the National Cancer Institute Marketwire (Thu, Jun 4)
| | Mon, Jun 1, 2009 | | | Lpath to Provide First Quarter 2009 Business Review and Clinical Update Conference Call on Thursday, June 4 at 4:30 p.m. ET Marketwire (Mon, Jun 1)
| | Fri, May 15, 2009 | | | LPATH, INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, May 15)
| | Mon, Apr 20, 2009 | | | Lpath Scientists and Collaborators Present Favorable New Study Data of Leading Cancer Drug Candidate, ASONEP(TM) Marketwire (Mon, Apr 20)
| | | Lpath Presents Compelling New Preclinical Results of Its Anti-Cancer Drug Candidate, Lpathomab(TM), at the AACR 100th Annual Meeting Marketwire (Mon, Apr 20)
| Add LPTN.OB News to My Yahoo!:

| |
|